Results 111 to 120 of about 62,243 (240)

Efficacy and safety of once‐weekly semaglutide 2.4 mg for weight management in participants from China: A prespecified analysis of the STEP 7 randomized clinical trial

Diabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2540-2551, May 2025.
Abstract Aim To evaluate the efficacy and safety of semaglutide 2.4 mg versus placebo for weight management in a population of Chinese adults with overweight or obesity. Materials and Methods In STEP 7 (NCT04251156), a double‐blind, phase 3a trial, adults from a predominantly East Asian population with overweight or obesity, with or without type 2 ...
Weijun Gu, Yibing Lu, Xinhua Ye, Guoyue Yuan, Dongmei Liu, Zewei Shen, Ning Zu, Yiming Mu   +7 more
wiley   +1 more source

Association between diabetes self‐management education attendance, hospital admissions and mortality in type 2 diabetes: A cohort analysis protocol

Diabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2377-2386, May 2025.
Abstract Introduction Type 2 diabetes is associated with excess hospital admissions and increased mortality. Structured diabetes self‐management education (DSME) is recommended internationally and is associated with improved self‐management skills, well‐being and minor improvements in glycated haemoglobin (HBA1c), but does it reduce hospital admissions
Gemma A. Lewis, David M. Hughes, Greg Irving, John Wilding, Kevin Hardy   +4 more
wiley   +1 more source

Gallbladder Disease

, 2020
Sohail R. Shah, George W. Holcomb
openaire   +1 more source

An overview of obesity‐related complications: The epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes

Diabetes, Obesity and Metabolism, Volume 27, Issue S2, Page 3-19, April 2025.
Abstract Obesity is a highly prevalent chronic multisystem disease associated with shortened life expectancy due to a number of adverse health outcomes. Epidemiological data link body weight and parameters of central fat distribution to an increasing risk for type 2 diabetes, hypertension, fatty liver diseases, cardiovascular diseases including ...
Matthias Blüher
wiley   +1 more source

Nutritional Factors Related to Canine Gallbladder Diseases-A Scoping Review. [PDF]

Vet Sci
Teixeira FA, Aicher KM, Duarte R.
europepmc   +1 more source

Real‐world use of liraglutide for weight management according to label in the United Kingdom: A cohort study using the Clinical Practice Research Datalink primary care databases

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess real‐world use of Saxenda® (liraglutide 3.0 mg) and off‐label use of Victoza® (liraglutide 1.2 mg/1.8 mg) for weight management and Saxenda® posology in the United Kingdom. Their similar doses and formulation pose a risk of inadvertent use due to their use for different indications.
Tarita Murray‐Thomas, John M. Dcruz, Nina M. Harder‐Lauridsen, Anne H. Olsen, Rachael Williams, Atheline Major‐Pedersen   +5 more
wiley   +1 more source

The difficult gallbladder: A safe approach to a dangerous problem [PDF]

, 2017
Brunt, L. Michael, Pucci, Michael J, Santos, B. Fernando   +2 more
core   +2 more sources

Endoscopic Management of Benign Gallbladder Diseases. [PDF]

Turk J Gastroenterol
Ji Y, Huang W, Guo J, Hu B.
europepmc   +1 more source

GLP‐1 receptor agonists and the risk for cancer: A meta‐analysis of randomized controlled trials

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess if there is a difference in the oncogenic risk between GLP‐1 RA and comparators in randomized controlled trials. Materials and Methods A meta‐analysis of randomized controlled trials comparing GLP‐1RA to any comparators for diabetes and/or obesity, lasting at least 52 weeks.
Giovanni Antonio Silverii, Christian Marinelli, Costanza Bettarini, Gloria Giovanna Del Vescovo, Matteo Monami, Edoardo Mannucci   +5 more
wiley   +1 more source

Current status of artificial intelligence analysis for the diagnosis of gallbladder diseases using ultrasonography: a scoping review. [PDF]

Transl Gastroenterol Hepatol
Wang X, Zhang H, Bai Z, Xie X, Feng Y.
europepmc   +1 more source